| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aortitis | 9 | 2023 | 74 | 4.200 |
Why?
|
| Myocardium | 26 | 2021 | 4775 | 2.990 |
Why?
|
| Amyloidosis | 11 | 2020 | 795 | 2.360 |
Why?
|
| Autopsy | 14 | 2022 | 1020 | 2.120 |
Why?
|
| Myocarditis | 8 | 2021 | 768 | 1.580 |
Why?
|
| Hydrogen Peroxide | 8 | 2008 | 730 | 1.550 |
Why?
|
| Giant Cell Arteritis | 7 | 2013 | 292 | 1.510 |
Why?
|
| Aorta | 8 | 2023 | 2062 | 1.390 |
Why?
|
| Cardiomyopathies | 6 | 2023 | 1911 | 1.350 |
Why?
|
| Tunica Intima | 5 | 2010 | 463 | 1.260 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group C | 6 | 2013 | 14 | 1.220 |
Why?
|
| Immunoglobulin G | 12 | 2023 | 4561 | 1.160 |
Why?
|
| Diagnosis, Differential | 34 | 2021 | 12954 | 1.080 |
Why?
|
| Shock, Cardiogenic | 3 | 2022 | 688 | 1.060 |
Why?
|
| Mesenteric Vascular Occlusion | 3 | 2014 | 97 | 1.050 |
Why?
|
| Mesenteric Arteries | 2 | 2014 | 183 | 0.980 |
Why?
|
| Cardiovascular System | 2 | 2022 | 828 | 0.960 |
Why?
|
| Heart Neoplasms | 6 | 2016 | 374 | 0.910 |
Why?
|
| Guanine Nucleotide Exchange Factors | 10 | 2013 | 581 | 0.910 |
Why?
|
| Temporal Arteries | 4 | 2013 | 128 | 0.910 |
Why?
|
| Coronary Aneurysm | 2 | 2018 | 237 | 0.840 |
Why?
|
| Aortic Diseases | 6 | 2023 | 743 | 0.800 |
Why?
|
| Macrophages | 6 | 2020 | 5651 | 0.770 |
Why?
|
| Pheochromocytoma | 2 | 2018 | 337 | 0.760 |
Why?
|
| Immune System Diseases | 3 | 2016 | 261 | 0.750 |
Why?
|
| Casein Kinase Ialpha | 3 | 2013 | 27 | 0.750 |
Why?
|
| Syncope | 4 | 2018 | 429 | 0.740 |
Why?
|
| Prosthesis Failure | 2 | 2020 | 1203 | 0.740 |
Why?
|
| Exanthema | 3 | 2022 | 501 | 0.710 |
Why?
|
| Fatal Outcome | 13 | 2020 | 1851 | 0.710 |
Why?
|
| Anemia, Hemolytic | 1 | 2020 | 168 | 0.700 |
Why?
|
| Hematuria | 1 | 2020 | 235 | 0.680 |
Why?
|
| Plaque, Atherosclerotic | 4 | 2019 | 1518 | 0.650 |
Why?
|
| Lung | 17 | 2022 | 9858 | 0.650 |
Why?
|
| beta 2-Microglobulin | 1 | 2019 | 315 | 0.640 |
Why?
|
| Coronary Vessels | 8 | 2023 | 3106 | 0.640 |
Why?
|
| Fluorescent Antibody Technique | 4 | 2012 | 2503 | 0.620 |
Why?
|
| Amyloid | 3 | 2017 | 795 | 0.620 |
Why?
|
| Pathology, Surgical | 3 | 2016 | 155 | 0.610 |
Why?
|
| Exostoses, Multiple Hereditary | 1 | 2017 | 29 | 0.610 |
Why?
|
| Heart Transplantation | 10 | 2019 | 3113 | 0.610 |
Why?
|
| Aorta, Thoracic | 6 | 2023 | 1084 | 0.600 |
Why?
|
| Tongue | 2 | 2011 | 404 | 0.590 |
Why?
|
| Aneurysm, False | 2 | 2017 | 276 | 0.590 |
Why?
|
| Echocardiography | 15 | 2021 | 5096 | 0.580 |
Why?
|
| Iron Overload | 1 | 2019 | 242 | 0.570 |
Why?
|
| Atrial Appendage | 2 | 2021 | 282 | 0.570 |
Why?
|
| Lipomatosis | 1 | 2017 | 112 | 0.570 |
Why?
|
| Amyloid Neuropathies, Familial | 2 | 2016 | 136 | 0.570 |
Why?
|
| Headache | 3 | 2022 | 1224 | 0.570 |
Why?
|
| Plasma Cells | 4 | 2015 | 593 | 0.570 |
Why?
|
| Arteritis | 2 | 2023 | 159 | 0.570 |
Why?
|
| Aged | 70 | 2022 | 163178 | 0.560 |
Why?
|
| Coronary Artery Disease | 7 | 2019 | 6485 | 0.550 |
Why?
|
| Mammary Arteries | 2 | 2007 | 70 | 0.550 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2018 | 124 | 0.550 |
Why?
|
| Humans | 162 | 2024 | 743811 | 0.540 |
Why?
|
| Heart Diseases | 10 | 2022 | 2789 | 0.540 |
Why?
|
| Male | 107 | 2023 | 349776 | 0.530 |
Why?
|
| Pulmonary Artery | 3 | 2021 | 1911 | 0.520 |
Why?
|
| Adrenal Glands | 1 | 2018 | 547 | 0.520 |
Why?
|
| Heart Septum | 1 | 2016 | 312 | 0.520 |
Why?
|
| Saphenous Vein | 1 | 2018 | 532 | 0.520 |
Why?
|
| Bacterial Infections | 2 | 2015 | 1400 | 0.510 |
Why?
|
| Popliteal Artery | 1 | 2017 | 317 | 0.510 |
Why?
|
| Telangiectasia, Hereditary Hemorrhagic | 1 | 2017 | 139 | 0.510 |
Why?
|
| Endocardium | 3 | 2020 | 263 | 0.500 |
Why?
|
| Splenectomy | 1 | 2016 | 394 | 0.500 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 2015 | 173 | 0.500 |
Why?
|
| Dyspnea | 8 | 2019 | 1303 | 0.500 |
Why?
|
| Aneurysm | 1 | 2018 | 339 | 0.500 |
Why?
|
| Heart | 7 | 2022 | 4460 | 0.490 |
Why?
|
| Takayasu Arteritis | 2 | 2013 | 96 | 0.490 |
Why?
|
| Middle Aged | 71 | 2022 | 213241 | 0.490 |
Why?
|
| Extracellular Fluid | 1 | 2015 | 167 | 0.480 |
Why?
|
| Endovascular Procedures | 4 | 2015 | 1980 | 0.480 |
Why?
|
| Hyperplasia | 5 | 2013 | 1185 | 0.470 |
Why?
|
| Cytochrome b Group | 1 | 2013 | 60 | 0.470 |
Why?
|
| Adrenal Gland Neoplasms | 2 | 2018 | 740 | 0.470 |
Why?
|
| Erythrocyte Transfusion | 1 | 2019 | 565 | 0.470 |
Why?
|
| Whole Body Imaging | 1 | 2015 | 282 | 0.460 |
Why?
|
| Autoimmune Diseases | 5 | 2012 | 2134 | 0.450 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2019 | 2074 | 0.450 |
Why?
|
| Mitral Valve | 2 | 2020 | 1491 | 0.440 |
Why?
|
| Carotid Artery Injuries | 1 | 2013 | 96 | 0.440 |
Why?
|
| Endocarditis, Bacterial | 2 | 2014 | 455 | 0.440 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2016 | 1265 | 0.440 |
Why?
|
| Carotid Artery, Common | 1 | 2013 | 183 | 0.430 |
Why?
|
| Pulmonary Embolism | 5 | 2021 | 2375 | 0.430 |
Why?
|
| Polymyalgia Rheumatica | 1 | 2012 | 54 | 0.430 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2013 | 174 | 0.430 |
Why?
|
| Tachycardia, Ventricular | 3 | 2018 | 1272 | 0.420 |
Why?
|
| Endothelium, Vascular | 6 | 2010 | 4459 | 0.420 |
Why?
|
| Amyloidosis, Familial | 1 | 2012 | 13 | 0.420 |
Why?
|
| Vasculitis | 3 | 2023 | 519 | 0.420 |
Why?
|
| Nervous System Diseases | 1 | 2022 | 1619 | 0.410 |
Why?
|
| Heart Valve Prosthesis | 1 | 2020 | 1489 | 0.410 |
Why?
|
| Vascular Diseases | 3 | 2022 | 1161 | 0.400 |
Why?
|
| Systemic Vasculitis | 1 | 2012 | 37 | 0.400 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2013 | 1503 | 0.400 |
Why?
|
| Aortic Valve | 3 | 2020 | 1920 | 0.390 |
Why?
|
| Female | 81 | 2023 | 380020 | 0.380 |
Why?
|
| Retroperitoneal Fibrosis | 1 | 2011 | 38 | 0.380 |
Why?
|
| Sarcoidosis | 1 | 2016 | 506 | 0.380 |
Why?
|
| Electrocardiography | 7 | 2021 | 6441 | 0.380 |
Why?
|
| Histological Techniques | 1 | 2011 | 198 | 0.380 |
Why?
|
| Surgical Procedures, Operative | 1 | 2022 | 1877 | 0.380 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2016 | 501 | 0.380 |
Why?
|
| Renal Dialysis | 2 | 2019 | 1783 | 0.370 |
Why?
|
| Iron | 1 | 2019 | 1774 | 0.370 |
Why?
|
| Prealbumin | 1 | 2012 | 207 | 0.370 |
Why?
|
| Diffuse Axonal Injury | 2 | 2009 | 49 | 0.360 |
Why?
|
| Cardiovascular Diseases | 5 | 2022 | 15142 | 0.360 |
Why?
|
| Edema | 4 | 2016 | 789 | 0.350 |
Why?
|
| Testicular Neoplasms | 1 | 2016 | 803 | 0.350 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2017 | 1131 | 0.340 |
Why?
|
| Coronary Artery Bypass | 3 | 2018 | 2288 | 0.340 |
Why?
|
| Body Height | 1 | 2016 | 1579 | 0.340 |
Why?
|
| DNA Mutational Analysis | 3 | 2021 | 4183 | 0.340 |
Why?
|
| Myxoma | 2 | 2007 | 130 | 0.330 |
Why?
|
| Receptors, Antigen, B-Cell | 4 | 2013 | 548 | 0.330 |
Why?
|
| Biopsy | 8 | 2019 | 6750 | 0.330 |
Why?
|
| Aged, 80 and over | 25 | 2021 | 57744 | 0.330 |
Why?
|
| Traumatology | 1 | 2009 | 88 | 0.330 |
Why?
|
| Axons | 5 | 2004 | 1685 | 0.330 |
Why?
|
| Aortic Rupture | 1 | 2012 | 312 | 0.330 |
Why?
|
| Venous Thromboembolism | 2 | 2018 | 1670 | 0.320 |
Why?
|
| Immunohistochemistry | 12 | 2021 | 11360 | 0.320 |
Why?
|
| Carotid Artery, Internal | 2 | 2008 | 445 | 0.320 |
Why?
|
| Mediastinal Diseases | 1 | 2008 | 89 | 0.310 |
Why?
|
| Pleural Effusion | 2 | 2015 | 337 | 0.310 |
Why?
|
| Chest Pain | 5 | 2019 | 1114 | 0.310 |
Why?
|
| Atherosclerosis | 4 | 2015 | 3445 | 0.310 |
Why?
|
| Polyvinyls | 1 | 2008 | 157 | 0.310 |
Why?
|
| Puerperal Disorders | 1 | 2010 | 275 | 0.310 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2008 | 250 | 0.300 |
Why?
|
| Liver Transplantation | 1 | 2019 | 2119 | 0.300 |
Why?
|
| Cell Proliferation | 9 | 2019 | 10477 | 0.300 |
Why?
|
| Calcinosis | 1 | 2016 | 1495 | 0.300 |
Why?
|
| Pericardium | 3 | 2020 | 667 | 0.300 |
Why?
|
| Casein Kinase I | 1 | 2007 | 47 | 0.300 |
Why?
|
| Stents | 5 | 2015 | 3280 | 0.290 |
Why?
|
| Brain Injuries | 6 | 2004 | 2029 | 0.290 |
Why?
|
| Heart Rupture, Post-Infarction | 1 | 2006 | 49 | 0.290 |
Why?
|
| Embolism | 2 | 2007 | 407 | 0.290 |
Why?
|
| Dura Mater | 1 | 2008 | 291 | 0.280 |
Why?
|
| Immunosuppressive Agents | 3 | 2021 | 4152 | 0.280 |
Why?
|
| Foreign Bodies | 1 | 2011 | 400 | 0.280 |
Why?
|
| Radiography | 8 | 2016 | 7010 | 0.280 |
Why?
|
| Hemosiderosis | 1 | 2007 | 71 | 0.280 |
Why?
|
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2008 | 289 | 0.280 |
Why?
|
| Heart Atria | 2 | 2011 | 1357 | 0.280 |
Why?
|
| Forensic Pathology | 2 | 2016 | 25 | 0.280 |
Why?
|
| Carotid Artery Diseases | 2 | 2014 | 875 | 0.280 |
Why?
|
| Specimen Handling | 1 | 2011 | 694 | 0.270 |
Why?
|
| Carotid Arteries | 2 | 2014 | 949 | 0.270 |
Why?
|
| Pulmonary Fibrosis | 1 | 2010 | 530 | 0.270 |
Why?
|
| Papillary Muscles | 1 | 2006 | 203 | 0.270 |
Why?
|
| Behavior Therapy | 1 | 2012 | 862 | 0.270 |
Why?
|
| Aortic Aneurysm, Abdominal | 2 | 2012 | 1187 | 0.270 |
Why?
|
| Radiography, Thoracic | 4 | 2020 | 1265 | 0.270 |
Why?
|
| Models, Organizational | 1 | 2009 | 574 | 0.270 |
Why?
|
| Adipose Tissue | 1 | 2017 | 3280 | 0.260 |
Why?
|
| Phloroglucinol | 1 | 2005 | 6 | 0.260 |
Why?
|
| Biomedical Research | 1 | 2021 | 3308 | 0.260 |
Why?
|
| Amoxicillin-Potassium Clavulanate Combination | 1 | 2005 | 30 | 0.260 |
Why?
|
| von Hippel-Lindau Disease | 1 | 2006 | 152 | 0.260 |
Why?
|
| Myocardial Infarction | 7 | 2017 | 11708 | 0.260 |
Why?
|
| Magnetic Resonance Imaging | 19 | 2023 | 35409 | 0.250 |
Why?
|
| Retinal Vasculitis | 1 | 2005 | 42 | 0.250 |
Why?
|
| Body Weight | 1 | 2016 | 4670 | 0.250 |
Why?
|
| Adult | 49 | 2024 | 213889 | 0.250 |
Why?
|
| Echocardiography, Transesophageal | 4 | 2018 | 1133 | 0.250 |
Why?
|
| Conducted Energy Weapon Injuries | 2 | 2014 | 2 | 0.250 |
Why?
|
| Tomography, X-Ray Computed | 12 | 2019 | 20121 | 0.250 |
Why?
|
| Staphylococcal Infections | 1 | 2014 | 1400 | 0.250 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2010 | 489 | 0.250 |
Why?
|
| Immunologic Factors | 2 | 2016 | 1580 | 0.240 |
Why?
|
| Bile Duct Neoplasms | 2 | 2022 | 567 | 0.240 |
Why?
|
| Cholangiocarcinoma | 2 | 2022 | 516 | 0.240 |
Why?
|
| Skin | 3 | 2014 | 4372 | 0.240 |
Why?
|
| Ulnar Artery | 1 | 2004 | 16 | 0.240 |
Why?
|
| Brain Stem | 1 | 2009 | 844 | 0.240 |
Why?
|
| Disease Progression | 8 | 2024 | 13273 | 0.240 |
Why?
|
| Axonal Transport | 1 | 2004 | 177 | 0.240 |
Why?
|
| T-Lymphocytes | 4 | 2019 | 10179 | 0.240 |
Why?
|
| Adenocarcinoma | 2 | 2019 | 6363 | 0.240 |
Why?
|
| Blood Chemical Analysis | 2 | 2020 | 440 | 0.230 |
Why?
|
| Lung Neoplasms | 6 | 2020 | 13112 | 0.230 |
Why?
|
| Societies, Medical | 4 | 2019 | 3740 | 0.230 |
Why?
|
| Recurrence | 4 | 2018 | 8337 | 0.230 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2008 | 933 | 0.230 |
Why?
|
| Reactive Oxygen Species | 3 | 2013 | 2077 | 0.230 |
Why?
|
| Urinalysis | 2 | 2020 | 369 | 0.230 |
Why?
|
| Confusion | 2 | 2017 | 275 | 0.230 |
Why?
|
| Radiotherapy | 1 | 2010 | 1533 | 0.220 |
Why?
|
| Fever | 5 | 2014 | 1616 | 0.220 |
Why?
|
| Head Injuries, Closed | 2 | 2003 | 139 | 0.220 |
Why?
|
| ras Proteins | 2 | 2005 | 1059 | 0.220 |
Why?
|
| Radiation Injuries | 1 | 2010 | 1180 | 0.220 |
Why?
|
| Radiography, Interventional | 3 | 2014 | 1095 | 0.220 |
Why?
|
| Myocardial Ischemia | 3 | 2014 | 2150 | 0.220 |
Why?
|
| Serum Albumin | 2 | 2016 | 675 | 0.220 |
Why?
|
| Organelles | 1 | 2004 | 264 | 0.210 |
Why?
|
| Predictive Value of Tests | 7 | 2021 | 15067 | 0.210 |
Why?
|
| Hodgkin Disease | 1 | 2010 | 1415 | 0.210 |
Why?
|
| Chronic Disease | 8 | 2021 | 9139 | 0.210 |
Why?
|
| Cumulative Trauma Disorders | 1 | 2004 | 147 | 0.210 |
Why?
|
| Endothelial Cells | 4 | 2021 | 3482 | 0.210 |
Why?
|
| Serum Amyloid A Protein | 2 | 2015 | 121 | 0.210 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3134 | 0.210 |
Why?
|
| Inflammation | 6 | 2021 | 10629 | 0.210 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3241 | 0.210 |
Why?
|
| Proteoglycans | 1 | 2005 | 837 | 0.200 |
Why?
|
| Lectins, C-Type | 1 | 2005 | 589 | 0.200 |
Why?
|
| Graft Rejection | 7 | 2015 | 4398 | 0.200 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2005 | 1284 | 0.200 |
Why?
|
| Amyloid beta-Protein Precursor | 4 | 2004 | 1121 | 0.200 |
Why?
|
| Angioplasty, Balloon | 4 | 2014 | 653 | 0.200 |
Why?
|
| Ventricular Fibrillation | 2 | 2014 | 538 | 0.200 |
Why?
|
| B-Lymphocytes | 6 | 2013 | 4665 | 0.200 |
Why?
|
| Prednisone | 3 | 2012 | 1574 | 0.200 |
Why?
|
| Respiratory Insufficiency | 2 | 2007 | 1199 | 0.200 |
Why?
|
| Receptors, Interleukin-6 | 2 | 2013 | 225 | 0.200 |
Why?
|
| Amino Acid Sequence | 13 | 2017 | 13809 | 0.200 |
Why?
|
| Glucocorticoids | 4 | 2012 | 2107 | 0.200 |
Why?
|
| Trigeminal Ganglion | 1 | 2022 | 186 | 0.190 |
Why?
|
| Kidney | 5 | 2021 | 7185 | 0.190 |
Why?
|
| Animals | 57 | 2022 | 168660 | 0.190 |
Why?
|
| Models, Neurological | 1 | 2009 | 1771 | 0.190 |
Why?
|
| Antibody Formation | 1 | 2005 | 1402 | 0.190 |
Why?
|
| Microscopy, Fluorescence | 1 | 2008 | 2692 | 0.190 |
Why?
|
| Hand Injuries | 1 | 2004 | 242 | 0.190 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2005 | 850 | 0.190 |
Why?
|
| Mutation | 11 | 2017 | 29777 | 0.190 |
Why?
|
| Computers, Handheld | 2 | 2013 | 208 | 0.190 |
Why?
|
| Ventricular Function, Left | 4 | 2020 | 3660 | 0.190 |
Why?
|
| Arteriosclerosis | 1 | 2005 | 1092 | 0.190 |
Why?
|
| Heart Failure | 7 | 2019 | 10896 | 0.180 |
Why?
|
| Treatment Outcome | 18 | 2021 | 63042 | 0.180 |
Why?
|
| Death, Sudden | 1 | 2022 | 302 | 0.180 |
Why?
|
| Weight Loss | 1 | 2012 | 2625 | 0.180 |
Why?
|
| Caspases | 2 | 2009 | 928 | 0.180 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 2 | 2022 | 188 | 0.180 |
Why?
|
| Troponin I | 2 | 2018 | 619 | 0.180 |
Why?
|
| Central Nervous System | 2 | 2009 | 1358 | 0.180 |
Why?
|
| In Situ Hybridization | 2 | 2021 | 1952 | 0.180 |
Why?
|
| Flavonoids | 1 | 2003 | 443 | 0.180 |
Why?
|
| Lymphocyte Activation | 7 | 2012 | 5524 | 0.180 |
Why?
|
| Heart Ventricles | 3 | 2016 | 3817 | 0.180 |
Why?
|
| Heart Arrest | 3 | 2014 | 1470 | 0.180 |
Why?
|
| Muscle Cells | 1 | 2020 | 197 | 0.180 |
Why?
|
| Multiple Myeloma | 1 | 2017 | 5185 | 0.170 |
Why?
|
| Lymphocytes | 3 | 2007 | 2615 | 0.170 |
Why?
|
| Ribonucleoproteins | 1 | 2002 | 380 | 0.170 |
Why?
|
| Vascular Neoplasms | 1 | 2021 | 175 | 0.170 |
Why?
|
| Translocation, Genetic | 2 | 2016 | 1420 | 0.170 |
Why?
|
| Spinal Cord Injuries | 2 | 2006 | 931 | 0.170 |
Why?
|
| Renal Artery Obstruction | 2 | 2014 | 248 | 0.170 |
Why?
|
| Aorta, Abdominal | 2 | 2012 | 646 | 0.160 |
Why?
|
| Mice, Knockout | 16 | 2017 | 14563 | 0.160 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2008 | 1391 | 0.160 |
Why?
|
| Vena Cava, Inferior | 1 | 2001 | 439 | 0.160 |
Why?
|
| Molecular Sequence Data | 11 | 2010 | 18107 | 0.160 |
Why?
|
| RNA, Viral | 3 | 2022 | 2901 | 0.160 |
Why?
|
| Marmota | 1 | 2017 | 12 | 0.160 |
Why?
|
| Camptothecin | 1 | 2021 | 576 | 0.160 |
Why?
|
| Paraproteinemias | 2 | 2012 | 246 | 0.160 |
Why?
|
| Subclavian Artery | 2 | 2015 | 130 | 0.160 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2019 | 294 | 0.160 |
Why?
|
| Hypertension, Pulmonary | 2 | 2021 | 1534 | 0.160 |
Why?
|
| Mass Spectrometry | 1 | 2005 | 2203 | 0.150 |
Why?
|
| Liver | 4 | 2021 | 7479 | 0.150 |
Why?
|
| Repressor Proteins | 4 | 2005 | 3024 | 0.150 |
Why?
|
| Polypharmacy | 1 | 2020 | 294 | 0.150 |
Why?
|
| Giant Cells | 1 | 2018 | 187 | 0.150 |
Why?
|
| Transferrin | 1 | 2019 | 295 | 0.150 |
Why?
|
| Prosthesis Design | 3 | 2017 | 2103 | 0.150 |
Why?
|
| Muscle Weakness | 1 | 2020 | 413 | 0.150 |
Why?
|
| Cardiomyopathy, Restrictive | 1 | 2017 | 60 | 0.150 |
Why?
|
| Embolization, Therapeutic | 2 | 2017 | 1392 | 0.150 |
Why?
|
| Hypothermia, Induced | 1 | 2003 | 752 | 0.150 |
Why?
|
| Phosphorylation | 7 | 2009 | 8436 | 0.150 |
Why?
|
| Enbucrilate | 1 | 2017 | 31 | 0.150 |
Why?
|
| Endarterectomy | 1 | 2018 | 195 | 0.150 |
Why?
|
| Ureteral Diseases | 1 | 2017 | 60 | 0.150 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2021 | 260 | 0.150 |
Why?
|
| Lung Diseases | 2 | 2008 | 1887 | 0.150 |
Why?
|
| Postoperative Period | 1 | 2022 | 1841 | 0.150 |
Why?
|
| Stroke Volume | 3 | 2020 | 5002 | 0.150 |
Why?
|
| Ventricular Dysfunction | 1 | 2018 | 143 | 0.150 |
Why?
|
| Elastic Tissue | 2 | 2015 | 65 | 0.150 |
Why?
|
| Hematologic Diseases | 1 | 2021 | 498 | 0.150 |
Why?
|
| Coronary Angiography | 4 | 2018 | 4576 | 0.150 |
Why?
|
| Zinc Fingers | 4 | 2005 | 583 | 0.150 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2019 | 323 | 0.150 |
Why?
|
| Interferons | 1 | 2020 | 706 | 0.150 |
Why?
|
| Terminology as Topic | 2 | 2016 | 1546 | 0.150 |
Why?
|
| Pyridines | 2 | 2013 | 2827 | 0.140 |
Why?
|
| Postural Balance | 1 | 2021 | 621 | 0.140 |
Why?
|
| Neuregulin-1 | 2 | 2009 | 142 | 0.140 |
Why?
|
| Cells, Cultured | 7 | 2013 | 19232 | 0.140 |
Why?
|
| Technetium Tc 99m Pyrophosphate | 1 | 2016 | 44 | 0.140 |
Why?
|
| Sepsis | 1 | 2011 | 2593 | 0.140 |
Why?
|
| Critical Care | 1 | 2009 | 2647 | 0.140 |
Why?
|
| Practice Guidelines as Topic | 2 | 2011 | 7270 | 0.140 |
Why?
|
| Neoplasms | 3 | 2021 | 21675 | 0.140 |
Why?
|
| Imidazoles | 1 | 2003 | 1206 | 0.140 |
Why?
|
| Epistaxis | 1 | 2017 | 111 | 0.140 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2020 | 459 | 0.140 |
Why?
|
| Septal Occluder Device | 1 | 2017 | 128 | 0.140 |
Why?
|
| DNA-Binding Proteins | 6 | 2004 | 9648 | 0.140 |
Why?
|
| Mice | 33 | 2022 | 81154 | 0.140 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2019 | 539 | 0.140 |
Why?
|
| Postmortem Changes | 1 | 2016 | 124 | 0.140 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2009 | 8300 | 0.140 |
Why?
|
| Ferritins | 1 | 2019 | 590 | 0.140 |
Why?
|
| Pathology, Clinical | 2 | 2010 | 368 | 0.140 |
Why?
|
| Cell Division | 3 | 2003 | 4568 | 0.130 |
Why?
|
| Fatigue | 2 | 2018 | 1530 | 0.130 |
Why?
|
| Risk Factors | 11 | 2024 | 72252 | 0.130 |
Why?
|
| Retrospective Studies | 13 | 2021 | 77410 | 0.130 |
Why?
|
| Angiotensin II | 3 | 2010 | 880 | 0.130 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2016 | 277 | 0.130 |
Why?
|
| Hypotension, Orthostatic | 1 | 2018 | 255 | 0.130 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 890 | 0.130 |
Why?
|
| Radiopharmaceuticals | 2 | 2016 | 2647 | 0.130 |
Why?
|
| Subcutaneous Tissue | 1 | 2015 | 135 | 0.130 |
Why?
|
| Immunoglobulin lambda-Chains | 1 | 2015 | 87 | 0.130 |
Why?
|
| Arthralgia | 2 | 2010 | 456 | 0.130 |
Why?
|
| Autoimmunity | 4 | 2013 | 1349 | 0.130 |
Why?
|
| Bone Marrow | 3 | 2021 | 2951 | 0.130 |
Why?
|
| Peroxidases | 2 | 2006 | 138 | 0.130 |
Why?
|
| Guanylate Cyclase | 1 | 1995 | 201 | 0.130 |
Why?
|
| Baltimore | 1 | 2015 | 230 | 0.120 |
Why?
|
| Oxidative Stress | 2 | 2006 | 3082 | 0.120 |
Why?
|
| Polyvinyl Alcohol | 1 | 2015 | 74 | 0.120 |
Why?
|
| Cardiomegaly | 2 | 2010 | 621 | 0.120 |
Why?
|
| Splanchnic Circulation | 1 | 2014 | 110 | 0.120 |
Why?
|
| Lymphatic Diseases | 1 | 2016 | 323 | 0.120 |
Why?
|
| Peritoneum | 1 | 2015 | 227 | 0.120 |
Why?
|
| Vena Cava Filters | 1 | 2017 | 253 | 0.120 |
Why?
|
| Neovascularization, Physiologic | 1 | 2002 | 1351 | 0.120 |
Why?
|
| Rocky Mountain Spotted Fever | 1 | 2014 | 19 | 0.120 |
Why?
|
| Pleura | 1 | 2015 | 235 | 0.120 |
Why?
|
| Hypertrophy | 2 | 2014 | 569 | 0.120 |
Why?
|
| Fibromuscular Dysplasia | 1 | 2014 | 58 | 0.120 |
Why?
|
| Rats | 12 | 2009 | 24250 | 0.120 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2017 | 902 | 0.120 |
Why?
|
| Protein Structure, Tertiary | 5 | 2005 | 3847 | 0.120 |
Why?
|
| Immunoconjugates | 1 | 2021 | 901 | 0.120 |
Why?
|
| Matrix Metalloproteinase 12 | 1 | 2013 | 48 | 0.120 |
Why?
|
| Reproducibility of Results | 8 | 2021 | 19894 | 0.120 |
Why?
|
| Bilirubin | 1 | 2015 | 425 | 0.120 |
Why?
|
| Lymphocyte Count | 2 | 2016 | 793 | 0.120 |
Why?
|
| Heme | 1 | 1995 | 306 | 0.120 |
Why?
|
| RNA, Messenger | 6 | 2015 | 13028 | 0.120 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2019 | 1142 | 0.120 |
Why?
|
| Ascites | 1 | 2015 | 344 | 0.110 |
Why?
|
| Phenylurea Compounds | 1 | 2016 | 528 | 0.110 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 2005 | 278 | 0.110 |
Why?
|
| Foramen Ovale, Patent | 1 | 2016 | 223 | 0.110 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 2 | 2012 | 343 | 0.110 |
Why?
|
| Diverticulum | 1 | 2014 | 134 | 0.110 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2019 | 5170 | 0.110 |
Why?
|
| Nuclear Medicine | 1 | 2016 | 233 | 0.110 |
Why?
|
| Smad4 Protein | 1 | 2014 | 163 | 0.110 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2013 | 148 | 0.110 |
Why?
|
| Flow Cytometry | 5 | 2017 | 5973 | 0.110 |
Why?
|
| Cryptorchidism | 1 | 2014 | 120 | 0.110 |
Why?
|
| Leg | 2 | 2016 | 1116 | 0.110 |
Why?
|
| Blast Injuries | 1 | 2016 | 302 | 0.110 |
Why?
|
| Muscular Diseases | 2 | 2008 | 555 | 0.110 |
Why?
|
| Neointima | 1 | 2013 | 135 | 0.110 |
Why?
|
| Pyrimidines | 3 | 2022 | 2945 | 0.110 |
Why?
|
| Hand Deformities, Congenital | 1 | 2014 | 146 | 0.110 |
Why?
|
| Donor Selection | 1 | 2014 | 201 | 0.110 |
Why?
|
| Military Personnel | 1 | 2021 | 1133 | 0.110 |
Why?
|
| Signal Transduction | 12 | 2016 | 23398 | 0.110 |
Why?
|
| Adhesives | 1 | 2012 | 61 | 0.110 |
Why?
|
| Antigens, CD | 2 | 2019 | 4026 | 0.110 |
Why?
|
| Stomach | 1 | 2017 | 697 | 0.110 |
Why?
|
| Teleradiology | 1 | 2012 | 53 | 0.110 |
Why?
|
| Apolipoproteins B | 1 | 2014 | 374 | 0.100 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2005 | 2839 | 0.100 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 1479 | 0.100 |
Why?
|
| Aneurysm, Infected | 1 | 2012 | 85 | 0.100 |
Why?
|
| New Mexico | 1 | 2012 | 86 | 0.100 |
Why?
|
| Aldosterone | 2 | 2010 | 877 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 16 | 2017 | 21824 | 0.100 |
Why?
|
| Up-Regulation | 4 | 2009 | 4221 | 0.100 |
Why?
|
| Cardiology | 2 | 2016 | 1668 | 0.100 |
Why?
|
| Prognosis | 4 | 2019 | 29052 | 0.100 |
Why?
|
| Acute Disease | 4 | 2016 | 7150 | 0.100 |
Why?
|
| Disease Models, Animal | 8 | 2022 | 18027 | 0.100 |
Why?
|
| Europe | 3 | 2019 | 3336 | 0.100 |
Why?
|
| Cause of Death | 1 | 2022 | 3580 | 0.100 |
Why?
|
| Syndrome | 1 | 2018 | 3249 | 0.100 |
Why?
|
| Coronary Stenosis | 2 | 2010 | 833 | 0.100 |
Why?
|
| Receptor, Angiotensin, Type 1 | 2 | 2010 | 152 | 0.100 |
Why?
|
| Cadaver | 1 | 2015 | 1335 | 0.100 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2014 | 340 | 0.100 |
Why?
|
| Brain Infarction | 1 | 2013 | 299 | 0.100 |
Why?
|
| E2F3 Transcription Factor | 2 | 2008 | 40 | 0.100 |
Why?
|
| NG-Nitroarginine Methyl Ester | 3 | 2010 | 254 | 0.100 |
Why?
|
| Isoxazoles | 1 | 2013 | 216 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2021 | 8939 | 0.100 |
Why?
|
| Myeloid Cells | 3 | 2017 | 808 | 0.100 |
Why?
|
| Streptococcus anginosus | 1 | 2011 | 24 | 0.100 |
Why?
|
| Aortic Aneurysm | 2 | 2021 | 644 | 0.100 |
Why?
|
| Case-Control Studies | 5 | 2016 | 21733 | 0.100 |
Why?
|
| Bronchography | 1 | 2011 | 74 | 0.100 |
Why?
|
| Radiology Information Systems | 2 | 2013 | 523 | 0.100 |
Why?
|
| Fusobacterium | 1 | 2011 | 54 | 0.100 |
Why?
|
| Gram-Positive Bacteria | 1 | 2012 | 185 | 0.100 |
Why?
|
| Molecular Weight | 2 | 2004 | 2253 | 0.100 |
Why?
|
| Thoracic Arteries | 1 | 2010 | 41 | 0.090 |
Why?
|
| Organ Size | 1 | 2016 | 2241 | 0.090 |
Why?
|
| Angiography | 2 | 2014 | 1638 | 0.090 |
Why?
|
| Pneumonia | 1 | 2022 | 2133 | 0.090 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2015 | 688 | 0.090 |
Why?
|
| Kinetics | 5 | 2005 | 6476 | 0.090 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2014 | 793 | 0.090 |
Why?
|
| Brain Abscess | 1 | 2011 | 119 | 0.090 |
Why?
|
| Hardness | 1 | 2009 | 36 | 0.090 |
Why?
|
| Comorbidity | 3 | 2020 | 10380 | 0.090 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2010 | 689 | 0.090 |
Why?
|
| Mitral Valve Insufficiency | 2 | 2015 | 1421 | 0.090 |
Why?
|
| Blotting, Western | 4 | 2015 | 5179 | 0.090 |
Why?
|
| Retinoblastoma-Like Protein p107 | 1 | 2009 | 74 | 0.090 |
Why?
|
| Migraine Disorders | 1 | 2022 | 1620 | 0.090 |
Why?
|
| Hematoma | 2 | 2005 | 758 | 0.090 |
Why?
|
| Renal Insufficiency | 2 | 2014 | 805 | 0.090 |
Why?
|
| Tongue Diseases | 1 | 2010 | 67 | 0.090 |
Why?
|
| Purines | 2 | 2019 | 590 | 0.090 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2013 | 693 | 0.090 |
Why?
|
| Joint Diseases | 1 | 2014 | 479 | 0.090 |
Why?
|
| Telepathology | 1 | 2009 | 76 | 0.090 |
Why?
|
| Carotid Stenosis | 2 | 2007 | 854 | 0.090 |
Why?
|
| Leukocytes | 1 | 2017 | 2044 | 0.090 |
Why?
|
| Syndecan-1 | 1 | 2010 | 165 | 0.090 |
Why?
|
| Bronchiectasis | 1 | 2010 | 128 | 0.080 |
Why?
|
| Sarcoma | 1 | 2021 | 1898 | 0.080 |
Why?
|
| Abdominal Pain | 2 | 2012 | 1064 | 0.080 |
Why?
|
| Influenza, Human | 1 | 2020 | 1480 | 0.080 |
Why?
|
| Oral Ulcer | 1 | 2010 | 96 | 0.080 |
Why?
|
| Amyloid beta-Peptides | 1 | 2002 | 3587 | 0.080 |
Why?
|
| Temperature | 2 | 2008 | 2202 | 0.080 |
Why?
|
| Ultrasonography | 4 | 2014 | 5986 | 0.080 |
Why?
|
| Radiography, Abdominal | 1 | 2012 | 537 | 0.080 |
Why?
|
| Stress, Psychological | 2 | 2014 | 4245 | 0.080 |
Why?
|
| Jaundice | 1 | 2009 | 89 | 0.080 |
Why?
|
| Behcet Syndrome | 1 | 2009 | 84 | 0.080 |
Why?
|
| Viscosity | 1 | 2009 | 328 | 0.080 |
Why?
|
| Pulmonary Alveoli | 2 | 2022 | 674 | 0.080 |
Why?
|
| Polyuria | 1 | 2008 | 39 | 0.080 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 3583 | 0.080 |
Why?
|
| Neutrophils | 4 | 2017 | 3718 | 0.080 |
Why?
|
| False Negative Reactions | 1 | 2010 | 588 | 0.080 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2015 | 691 | 0.080 |
Why?
|
| Growth Disorders | 1 | 2014 | 645 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 4749 | 0.080 |
Why?
|
| Aneurysm, Ruptured | 1 | 2014 | 452 | 0.080 |
Why?
|
| Elastic Modulus | 1 | 2009 | 214 | 0.080 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2016 | 1821 | 0.080 |
Why?
|
| Defibrillators, Implantable | 1 | 2018 | 1439 | 0.080 |
Why?
|
| Necrosis | 2 | 2011 | 1642 | 0.080 |
Why?
|
| Diagnostic Techniques, Cardiovascular | 1 | 2009 | 153 | 0.080 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2016 | 1660 | 0.080 |
Why?
|
| Monocytes | 3 | 2017 | 2593 | 0.080 |
Why?
|
| Natural Killer T-Cells | 1 | 2011 | 316 | 0.080 |
Why?
|
| Caveolin 1 | 1 | 2010 | 263 | 0.080 |
Why?
|
| rap GTP-Binding Proteins | 1 | 2007 | 28 | 0.080 |
Why?
|
| Brain | 7 | 2019 | 26345 | 0.080 |
Why?
|
| Phorbol Esters | 2 | 2007 | 111 | 0.080 |
Why?
|
| Brain Concussion | 1 | 2019 | 1320 | 0.080 |
Why?
|
| Catheterization | 1 | 2013 | 1469 | 0.080 |
Why?
|
| Shock | 1 | 2010 | 318 | 0.080 |
Why?
|
| rap1 GTP-Binding Proteins | 1 | 2007 | 60 | 0.080 |
Why?
|
| Lymph Nodes | 2 | 2016 | 3476 | 0.080 |
Why?
|
| Genes, ras | 2 | 2009 | 690 | 0.080 |
Why?
|
| Protein Splicing | 1 | 2007 | 17 | 0.080 |
Why?
|
| Heart-Assist Devices | 1 | 2018 | 1195 | 0.080 |
Why?
|
| Solvents | 1 | 2008 | 302 | 0.080 |
Why?
|
| Heart Valve Diseases | 1 | 2015 | 1073 | 0.080 |
Why?
|
| Chimera | 1 | 2009 | 484 | 0.070 |
Why?
|
| Patient Care Planning | 1 | 2013 | 915 | 0.070 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 8637 | 0.070 |
Why?
|
| Tinnitus | 1 | 2010 | 195 | 0.070 |
Why?
|
| Ventricular Remodeling | 1 | 2015 | 1225 | 0.070 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2007 | 101 | 0.070 |
Why?
|
| Mice, Mutant Strains | 3 | 2005 | 1862 | 0.070 |
Why?
|
| Drug Resistance | 1 | 2013 | 1606 | 0.070 |
Why?
|
| Pulmonary Edema | 2 | 2007 | 414 | 0.070 |
Why?
|
| Binding Sites | 4 | 2014 | 6111 | 0.070 |
Why?
|
| Remote Consultation | 1 | 2009 | 239 | 0.070 |
Why?
|
| Molecular Imaging | 1 | 2014 | 821 | 0.070 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 2 | 2008 | 281 | 0.070 |
Why?
|
| Time | 1 | 2008 | 542 | 0.070 |
Why?
|
| Embolectomy | 1 | 2007 | 120 | 0.070 |
Why?
|
| Blood Vessels | 1 | 2012 | 1124 | 0.070 |
Why?
|
| Cell Differentiation | 4 | 2012 | 11478 | 0.070 |
Why?
|
| Spinal Puncture | 1 | 2008 | 281 | 0.070 |
Why?
|
| Nitric Oxide | 1 | 1995 | 2132 | 0.070 |
Why?
|
| Bronchi | 1 | 2011 | 840 | 0.070 |
Why?
|
| Lower Extremity | 1 | 2014 | 1158 | 0.070 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2008 | 960 | 0.070 |
Why?
|
| Coronary Thrombosis | 1 | 2010 | 495 | 0.070 |
Why?
|
| Multiple Organ Failure | 1 | 2009 | 389 | 0.070 |
Why?
|
| Receptors, Antigen, T-Cell | 3 | 2006 | 2540 | 0.070 |
Why?
|
| Optic Neuritis | 1 | 2008 | 166 | 0.070 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2001 | 3142 | 0.070 |
Why?
|
| Mice, Nude | 2 | 2019 | 3680 | 0.070 |
Why?
|
| Vocal Cord Paralysis | 1 | 2010 | 267 | 0.070 |
Why?
|
| Paresis | 1 | 2007 | 180 | 0.070 |
Why?
|
| Tissue and Organ Procurement | 1 | 2014 | 896 | 0.070 |
Why?
|
| Cell Count | 1 | 2010 | 1855 | 0.070 |
Why?
|
| Jogging | 1 | 2005 | 18 | 0.070 |
Why?
|
| Hypesthesia | 1 | 2006 | 109 | 0.070 |
Why?
|
| Thrombocytopenia | 1 | 2014 | 1178 | 0.070 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2013 | 4552 | 0.070 |
Why?
|
| Appendicitis | 1 | 2012 | 645 | 0.070 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2022 | 1542 | 0.070 |
Why?
|
| Cell Nucleus | 2 | 2007 | 2969 | 0.070 |
Why?
|
| Anticoagulants | 1 | 2021 | 4599 | 0.070 |
Why?
|
| Iliac Artery | 1 | 2007 | 364 | 0.070 |
Why?
|
| Ischemia | 1 | 2014 | 1907 | 0.070 |
Why?
|
| Sotalol | 1 | 2005 | 49 | 0.070 |
Why?
|
| Surface Properties | 1 | 2008 | 1168 | 0.070 |
Why?
|
| Chemokines | 5 | 2017 | 968 | 0.070 |
Why?
|
| Blindness | 1 | 2010 | 612 | 0.070 |
Why?
|
| Retinoblastoma Protein | 1 | 2009 | 705 | 0.070 |
Why?
|
| Staphylococcus aureus | 1 | 2014 | 1453 | 0.070 |
Why?
|
| Pilonidal Sinus | 1 | 2005 | 16 | 0.070 |
Why?
|
| Immunoglobulin Isotypes | 1 | 2005 | 158 | 0.070 |
Why?
|
| Aggrecans | 1 | 2005 | 90 | 0.070 |
Why?
|
| Dexamethasone | 1 | 2012 | 1950 | 0.070 |
Why?
|
| Postoperative Complications | 4 | 2015 | 15281 | 0.070 |
Why?
|
| Apoptosis | 6 | 2019 | 9718 | 0.060 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 3503 | 0.060 |
Why?
|
| Transfection | 1 | 2013 | 5892 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 3 | 2019 | 6311 | 0.060 |
Why?
|
| Metoprolol | 1 | 2005 | 93 | 0.060 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2017 | 2217 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2022 | 5532 | 0.060 |
Why?
|
| Proteinuria | 2 | 2005 | 658 | 0.060 |
Why?
|
| Materials Testing | 1 | 2008 | 866 | 0.060 |
Why?
|
| Immunoenzyme Techniques | 1 | 2008 | 1799 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2012 | 10940 | 0.060 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2006 | 141 | 0.060 |
Why?
|
| Exercise Test | 1 | 2012 | 2074 | 0.060 |
Why?
|
| Pulmonary Veins | 1 | 2011 | 761 | 0.060 |
Why?
|
| Intermittent Claudication | 1 | 2007 | 309 | 0.060 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2005 | 306 | 0.060 |
Why?
|
| Kidney Neoplasms | 1 | 2001 | 4260 | 0.060 |
Why?
|
| Hypolipidemic Agents | 1 | 2009 | 606 | 0.060 |
Why?
|
| Paraganglioma | 1 | 2006 | 143 | 0.060 |
Why?
|
| Exercise Therapy | 1 | 2012 | 904 | 0.060 |
Why?
|
| Congresses as Topic | 1 | 2009 | 763 | 0.060 |
Why?
|
| Chemotaxis | 1 | 2007 | 607 | 0.060 |
Why?
|
| Multigene Family | 1 | 2008 | 1101 | 0.060 |
Why?
|
| Troponin T | 1 | 2009 | 754 | 0.060 |
Why?
|
| RNA Interference | 1 | 2013 | 2890 | 0.060 |
Why?
|
| Plants | 1 | 2006 | 316 | 0.060 |
Why?
|
| Thrombophlebitis | 1 | 2005 | 309 | 0.060 |
Why?
|
| Immune Tolerance | 1 | 2013 | 2258 | 0.060 |
Why?
|
| Purpura | 1 | 2005 | 122 | 0.060 |
Why?
|
| Contrast Media | 5 | 2020 | 5301 | 0.060 |
Why?
|
| Cardiac Output, Low | 1 | 2005 | 195 | 0.060 |
Why?
|
| Methylprednisolone | 1 | 2006 | 387 | 0.060 |
Why?
|
| Pharyngitis | 1 | 2006 | 215 | 0.060 |
Why?
|
| Blood Pressure | 2 | 2018 | 8551 | 0.060 |
Why?
|
| Dimerization | 2 | 2005 | 894 | 0.060 |
Why?
|
| Antigens | 1 | 2009 | 1466 | 0.060 |
Why?
|
| Bacteremia | 1 | 2011 | 963 | 0.060 |
Why?
|
| Hypotension | 2 | 2007 | 884 | 0.060 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2012 | 1837 | 0.060 |
Why?
|
| Membrane Proteins | 5 | 2013 | 7880 | 0.060 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2013 | 2453 | 0.060 |
Why?
|
| Follow-Up Studies | 6 | 2017 | 39001 | 0.060 |
Why?
|
| Time Factors | 4 | 2021 | 40038 | 0.060 |
Why?
|
| Nausea | 1 | 2006 | 674 | 0.060 |
Why?
|
| Sequence Deletion | 1 | 2008 | 1524 | 0.060 |
Why?
|
| NF-kappa B | 2 | 2002 | 2500 | 0.060 |
Why?
|
| Unconsciousness | 1 | 2005 | 263 | 0.060 |
Why?
|
| Diacylglycerol Kinase | 1 | 2003 | 48 | 0.060 |
Why?
|
| Cyclooxygenase 1 | 1 | 2003 | 104 | 0.060 |
Why?
|
| Microscopy, Confocal | 2 | 2014 | 1962 | 0.060 |
Why?
|
| Embryo, Mammalian | 1 | 2009 | 1702 | 0.060 |
Why?
|
| Nutritional Status | 1 | 2012 | 1608 | 0.060 |
Why?
|
| Kidney Diseases | 3 | 2013 | 2146 | 0.060 |
Why?
|
| Models, Animal | 3 | 2008 | 2172 | 0.060 |
Why?
|
| Eosinophilia | 1 | 2007 | 541 | 0.060 |
Why?
|
| Interprofessional Relations | 1 | 2009 | 1009 | 0.060 |
Why?
|
| Program Evaluation | 1 | 2012 | 2483 | 0.060 |
Why?
|
| Adolescent | 9 | 2022 | 85729 | 0.060 |
Why?
|
| Cardiovascular Agents | 1 | 2009 | 850 | 0.060 |
Why?
|
| Prospective Studies | 6 | 2023 | 53250 | 0.050 |
Why?
|
| Pyrazoles | 1 | 2013 | 1970 | 0.050 |
Why?
|
| Transcription Factors | 4 | 2004 | 12209 | 0.050 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2016 | 3320 | 0.050 |
Why?
|
| Doxorubicin | 2 | 2009 | 2234 | 0.050 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2005 | 505 | 0.050 |
Why?
|
| Running | 1 | 2007 | 479 | 0.050 |
Why?
|
| Cytokines | 7 | 2016 | 7324 | 0.050 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2005 | 688 | 0.050 |
Why?
|
| Young Adult | 7 | 2022 | 56392 | 0.050 |
Why?
|
| Dextrans | 1 | 2004 | 595 | 0.050 |
Why?
|
| Permeability | 1 | 2004 | 738 | 0.050 |
Why?
|
| Sulfhydryl Compounds | 1 | 2004 | 298 | 0.050 |
Why?
|
| Lipid Peroxidation | 1 | 2003 | 270 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2005 | 1574 | 0.050 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 329 | 0.050 |
Why?
|
| Free Radical Scavengers | 1 | 2003 | 216 | 0.050 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 906 | 0.050 |
Why?
|
| Organ Specificity | 2 | 2021 | 2008 | 0.050 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2021 | 11524 | 0.050 |
Why?
|
| Interleukin-4 | 1 | 2006 | 1147 | 0.050 |
Why?
|
| Spleen | 3 | 2013 | 2359 | 0.050 |
Why?
|
| Graft Enhancement, Immunologic | 1 | 2001 | 59 | 0.050 |
Why?
|
| Chromatography | 1 | 2001 | 206 | 0.050 |
Why?
|
| Immunoblotting | 2 | 2003 | 1683 | 0.050 |
Why?
|
| Severity of Illness Index | 3 | 2015 | 15526 | 0.050 |
Why?
|
| Boston | 1 | 2015 | 9310 | 0.050 |
Why?
|
| Dyslipidemias | 1 | 2009 | 851 | 0.050 |
Why?
|
| Cohort Studies | 4 | 2021 | 40545 | 0.050 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2002 | 70 | 0.050 |
Why?
|
| Cell Survival | 3 | 2008 | 5881 | 0.050 |
Why?
|
| Viral Load | 2 | 2021 | 3300 | 0.050 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2008 | 1203 | 0.050 |
Why?
|
| Arachidonic Acid | 1 | 2003 | 434 | 0.050 |
Why?
|
| Risk Assessment | 5 | 2014 | 23327 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 4251 | 0.050 |
Why?
|
| Patient Compliance | 1 | 2012 | 2683 | 0.050 |
Why?
|
| Protein Denaturation | 1 | 2001 | 237 | 0.050 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2004 | 473 | 0.050 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2003 | 277 | 0.050 |
Why?
|
| Isoenzymes | 2 | 2003 | 1728 | 0.050 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2003 | 271 | 0.050 |
Why?
|
| Circular Dichroism | 1 | 2001 | 353 | 0.050 |
Why?
|
| Intestines | 1 | 2011 | 1923 | 0.050 |
Why?
|
| Benzhydryl Compounds | 1 | 2007 | 844 | 0.050 |
Why?
|
| Capsid Proteins | 1 | 2005 | 479 | 0.050 |
Why?
|
| Umbilical Veins | 1 | 2002 | 433 | 0.050 |
Why?
|
| Placenta | 1 | 2010 | 1699 | 0.050 |
Why?
|
| Mice, Transgenic | 6 | 2017 | 9731 | 0.050 |
Why?
|
| Trypsin | 1 | 2002 | 511 | 0.050 |
Why?
|
| Lymphoma | 1 | 2010 | 1875 | 0.050 |
Why?
|
| K562 Cells | 1 | 2003 | 635 | 0.050 |
Why?
|
| Serine | 1 | 2005 | 825 | 0.050 |
Why?
|
| Explosions | 1 | 2021 | 108 | 0.050 |
Why?
|
| Estradiol | 1 | 2008 | 2017 | 0.050 |
Why?
|
| Diagnostic Errors | 1 | 2008 | 1256 | 0.050 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2003 | 401 | 0.050 |
Why?
|
| Hand | 1 | 2006 | 884 | 0.050 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2005 | 788 | 0.050 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2001 | 1800 | 0.050 |
Why?
|
| Chickens | 1 | 2003 | 864 | 0.050 |
Why?
|
| Fibroblasts | 2 | 2021 | 4162 | 0.050 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2022 | 295 | 0.050 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2003 | 367 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 6 | 2010 | 6380 | 0.050 |
Why?
|
| Cyclooxygenase 2 | 1 | 2003 | 612 | 0.050 |
Why?
|
| DNA | 2 | 2014 | 7295 | 0.050 |
Why?
|
| Vitamin A | 1 | 2003 | 615 | 0.050 |
Why?
|
| Transplantation Immunology | 1 | 2002 | 546 | 0.050 |
Why?
|
| Stroke | 1 | 2023 | 9975 | 0.050 |
Why?
|
| Surface-Active Agents | 1 | 2020 | 159 | 0.050 |
Why?
|
| Thermodynamics | 1 | 2001 | 595 | 0.050 |
Why?
|
| Brain Mapping | 1 | 2016 | 6622 | 0.050 |
Why?
|
| Cyclosporine | 1 | 2003 | 788 | 0.050 |
Why?
|
| Life Style | 1 | 2012 | 3833 | 0.040 |
Why?
|
| CHO Cells | 1 | 2003 | 1409 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 8385 | 0.040 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2002 | 504 | 0.040 |
Why?
|
| Emergency Medicine | 1 | 2009 | 1205 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 2002 | 1095 | 0.040 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2005 | 858 | 0.040 |
Why?
|
| Shock, Septic | 1 | 2006 | 775 | 0.040 |
Why?
|
| Software | 1 | 2014 | 4440 | 0.040 |
Why?
|
| Recombinant Proteins | 3 | 2009 | 6620 | 0.040 |
Why?
|
| Peptide Fragments | 2 | 2003 | 5096 | 0.040 |
Why?
|
| Atlases as Topic | 1 | 2021 | 237 | 0.040 |
Why?
|
| Caspase 3 | 1 | 2002 | 758 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2003 | 697 | 0.040 |
Why?
|
| Mitochondrial Diseases | 1 | 2003 | 320 | 0.040 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2010 | 2104 | 0.040 |
Why?
|
| Ethanol | 1 | 2006 | 1343 | 0.040 |
Why?
|
| Phagocytes | 1 | 2021 | 296 | 0.040 |
Why?
|
| Cysteine | 1 | 2004 | 871 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 595 | 0.040 |
Why?
|
| Cricetinae | 1 | 2003 | 2475 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2014 | 4687 | 0.040 |
Why?
|
| Central Nervous System Stimulants | 1 | 2007 | 1148 | 0.040 |
Why?
|
| Aspartic Acid Endopeptidases | 1 | 2020 | 311 | 0.040 |
Why?
|
| Peroxidase | 2 | 2014 | 611 | 0.040 |
Why?
|
| Drug Hypersensitivity | 1 | 2007 | 884 | 0.040 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2016 | 4266 | 0.040 |
Why?
|
| Receptors, Chemokine | 4 | 2003 | 670 | 0.040 |
Why?
|
| Epithelial Cells | 2 | 2021 | 3690 | 0.040 |
Why?
|
| Diagnostic Imaging | 2 | 2010 | 3503 | 0.040 |
Why?
|
| Protein Structure, Secondary | 1 | 2001 | 1245 | 0.040 |
Why?
|
| Pedigree | 1 | 2006 | 4643 | 0.040 |
Why?
|
| RNA | 2 | 2007 | 2748 | 0.040 |
Why?
|
| Hypertension | 3 | 2007 | 8480 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2005 | 1781 | 0.040 |
Why?
|
| Breast Neoplasms | 2 | 2019 | 20827 | 0.040 |
Why?
|
| Protein Folding | 1 | 2001 | 840 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 2 | 2012 | 805 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2006 | 1809 | 0.040 |
Why?
|
| Cell Cycle Proteins | 2 | 2016 | 3463 | 0.040 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2019 | 323 | 0.040 |
Why?
|
| Wound Healing | 1 | 2009 | 2776 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2003 | 2556 | 0.040 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2006 | 895 | 0.040 |
Why?
|
| Cytokine Receptor Common beta Subunit | 1 | 2017 | 22 | 0.040 |
Why?
|
| Vision Disorders | 1 | 2005 | 1055 | 0.040 |
Why?
|
| Cerebral Cortex | 1 | 2014 | 5692 | 0.040 |
Why?
|
| Emergency Medical Services | 1 | 2009 | 1917 | 0.040 |
Why?
|
| Physical Therapy Modalities | 1 | 2021 | 549 | 0.040 |
Why?
|
| Isoantibodies | 1 | 2001 | 679 | 0.040 |
Why?
|
| Biosensing Techniques | 1 | 2004 | 667 | 0.040 |
Why?
|
| Genetic Heterogeneity | 1 | 2021 | 733 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2010 | 2291 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2016 | 5230 | 0.040 |
Why?
|
| Mucins | 1 | 2020 | 564 | 0.040 |
Why?
|
| Transcription Factor TFIIIA | 1 | 2016 | 25 | 0.040 |
Why?
|
| Anemia | 1 | 2007 | 1502 | 0.040 |
Why?
|
| Graft Survival | 3 | 2002 | 3734 | 0.040 |
Why?
|
| Oxygen Consumption | 1 | 2003 | 1869 | 0.040 |
Why?
|
| Sensitivity and Specificity | 3 | 2021 | 14714 | 0.040 |
Why?
|
| Infant | 2 | 2022 | 35122 | 0.040 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2001 | 1475 | 0.040 |
Why?
|
| Colon | 1 | 2005 | 1772 | 0.040 |
Why?
|
| Receptors, Estrogen | 2 | 2019 | 2190 | 0.040 |
Why?
|
| Pericardial Effusion | 2 | 2010 | 247 | 0.040 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2004 | 1874 | 0.040 |
Why?
|
| Apolipoproteins E | 2 | 2012 | 1436 | 0.040 |
Why?
|
| Transplantation, Isogeneic | 2 | 2010 | 257 | 0.040 |
Why?
|
| Fluorescent Dyes | 1 | 2004 | 1903 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2003 | 3701 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2003 | 3130 | 0.040 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2016 | 105 | 0.040 |
Why?
|
| Protein Conformation | 2 | 2013 | 4009 | 0.030 |
Why?
|
| Indoles | 1 | 2005 | 1841 | 0.030 |
Why?
|
| Plasmids | 1 | 2001 | 2308 | 0.030 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2003 | 795 | 0.030 |
Why?
|
| Antibodies | 1 | 2004 | 2459 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 1434 | 0.030 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2017 | 341 | 0.030 |
Why?
|
| Exercise | 1 | 2012 | 5611 | 0.030 |
Why?
|
| Submandibular Gland | 1 | 2016 | 86 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2009 | 4477 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2005 | 1940 | 0.030 |
Why?
|
| Feces | 1 | 2022 | 1397 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2006 | 1789 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 17439 | 0.030 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 709 | 0.030 |
Why?
|
| Rats, Long-Evans | 1 | 2016 | 387 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2006 | 4386 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2009 | 6188 | 0.030 |
Why?
|
| Aminopyridines | 1 | 2019 | 543 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2022 | 814 | 0.030 |
Why?
|
| Virginia | 1 | 2015 | 121 | 0.030 |
Why?
|
| Point Mutation | 1 | 2021 | 1623 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2003 | 3772 | 0.030 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2008 | 1813 | 0.030 |
Why?
|
| Retroperitoneal Space | 1 | 2016 | 176 | 0.030 |
Why?
|
| Spectrophotometry | 1 | 1995 | 313 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2013 | 1157 | 0.030 |
Why?
|
| Protein Binding | 2 | 2005 | 9377 | 0.030 |
Why?
|
| Tunica Media | 1 | 2015 | 112 | 0.030 |
Why?
|
| Child, Preschool | 3 | 2022 | 40964 | 0.030 |
Why?
|
| Exploratory Behavior | 1 | 2016 | 270 | 0.030 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2001 | 1366 | 0.030 |
Why?
|
| Rats, Wistar | 2 | 2009 | 1892 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 2021 | 1602 | 0.030 |
Why?
|
| Gadolinium | 1 | 2020 | 950 | 0.030 |
Why?
|
| Hemorrhage | 1 | 2007 | 3458 | 0.030 |
Why?
|
| Nasal Septum | 1 | 2016 | 127 | 0.030 |
Why?
|
| Neurons | 3 | 2022 | 9336 | 0.030 |
Why?
|
| Immunity | 1 | 2020 | 1013 | 0.030 |
Why?
|
| Bundle-Branch Block | 1 | 2016 | 269 | 0.030 |
Why?
|
| Movement | 1 | 2021 | 1471 | 0.030 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2014 | 1444 | 0.030 |
Why?
|
| Dilatation, Pathologic | 1 | 2015 | 520 | 0.030 |
Why?
|
| Escherichia coli | 2 | 2005 | 4216 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2001 | 1743 | 0.030 |
Why?
|
| Reference Values | 1 | 2021 | 4974 | 0.030 |
Why?
|
| Endothelin-1 | 1 | 2015 | 314 | 0.030 |
Why?
|
| Gene Fusion | 1 | 2016 | 371 | 0.030 |
Why?
|
| Rheumatology | 1 | 2019 | 576 | 0.030 |
Why?
|
| Quantitative Trait Loci | 1 | 2021 | 2018 | 0.030 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2020 | 962 | 0.030 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2014 | 205 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2001 | 3617 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 13691 | 0.030 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2009 | 4033 | 0.030 |
Why?
|
| Base Sequence | 3 | 2017 | 12798 | 0.030 |
Why?
|
| Antigens, Neoplasm | 1 | 2021 | 1988 | 0.030 |
Why?
|
| Heterozygote | 2 | 2014 | 2803 | 0.030 |
Why?
|
| Facies | 1 | 2014 | 197 | 0.030 |
Why?
|
| Adhesiveness | 1 | 2012 | 53 | 0.030 |
Why?
|
| Athletic Injuries | 1 | 2003 | 1154 | 0.030 |
Why?
|
| Piperazines | 1 | 2003 | 2487 | 0.030 |
Why?
|
| Triiodobenzoic Acids | 1 | 2013 | 124 | 0.030 |
Why?
|
| Catechols | 1 | 2012 | 61 | 0.030 |
Why?
|
| Colitis, Ulcerative | 1 | 2005 | 1911 | 0.030 |
Why?
|
| Vertebral Artery | 1 | 2014 | 192 | 0.030 |
Why?
|
| Protein Transport | 3 | 2003 | 1988 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2021 | 1937 | 0.030 |
Why?
|
| Implants, Experimental | 1 | 2012 | 104 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2005 | 644 | 0.030 |
Why?
|
| Logistic Models | 1 | 2007 | 13404 | 0.030 |
Why?
|
| Genome-Wide Association Study | 2 | 2021 | 12259 | 0.030 |
Why?
|
| Iohexol | 1 | 2013 | 196 | 0.030 |
Why?
|
| Back Pain | 1 | 2016 | 544 | 0.030 |
Why?
|
| Renal Artery | 1 | 2014 | 399 | 0.030 |
Why?
|
| Regeneration | 1 | 2021 | 1486 | 0.030 |
Why?
|
| Limb Salvage | 1 | 2014 | 433 | 0.030 |
Why?
|
| Sheep | 1 | 2015 | 1437 | 0.030 |
Why?
|
| Proteomics | 1 | 2005 | 3639 | 0.030 |
Why?
|
| Oxygen | 1 | 2003 | 4189 | 0.030 |
Why?
|
| Skin Neoplasms | 2 | 2009 | 5691 | 0.030 |
Why?
|
| Auditory Perception | 1 | 2016 | 566 | 0.030 |
Why?
|
| Random Allocation | 1 | 2016 | 2429 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2008 | 3750 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2021 | 2440 | 0.030 |
Why?
|
| Injections | 1 | 2015 | 839 | 0.030 |
Why?
|
| Peptides | 1 | 2004 | 4406 | 0.030 |
Why?
|
| Gels | 1 | 2012 | 425 | 0.020 |
Why?
|
| I-kappa B Proteins | 2 | 2002 | 225 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 3547 | 0.020 |
Why?
|
| Appendix | 1 | 2012 | 110 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2019 | 8430 | 0.020 |
Why?
|
| Pregnancy | 2 | 2010 | 29140 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 1995 | 2256 | 0.020 |
Why?
|
| Solubility | 1 | 2012 | 1088 | 0.020 |
Why?
|
| Membrane Transport Proteins | 1 | 2016 | 1030 | 0.020 |
Why?
|
| Abdominal Abscess | 1 | 2012 | 154 | 0.020 |
Why?
|
| Pulmonary Emphysema | 1 | 2016 | 672 | 0.020 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2006 | 3255 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2024 | 25032 | 0.020 |
Why?
|
| Germinal Center | 1 | 2013 | 377 | 0.020 |
Why?
|
| Animals, Newborn | 2 | 2009 | 2725 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2177 | 0.020 |
Why?
|
| Pain | 1 | 2006 | 4987 | 0.020 |
Why?
|
| Consensus | 1 | 2019 | 2954 | 0.020 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2016 | 1038 | 0.020 |
Why?
|
| Smoking | 1 | 2007 | 8984 | 0.020 |
Why?
|
| Age Factors | 1 | 2007 | 18355 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2021 | 2727 | 0.020 |
Why?
|
| Prescriptions | 1 | 2012 | 387 | 0.020 |
Why?
|
| Toll-Like Receptors | 1 | 2013 | 593 | 0.020 |
Why?
|
| Sex Factors | 1 | 2004 | 10394 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2020 | 3758 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2003 | 5021 | 0.020 |
Why?
|
| Cattle | 1 | 1995 | 3917 | 0.020 |
Why?
|
| Survival Rate | 2 | 2015 | 12786 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2012 | 6356 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2017 | 10251 | 0.020 |
Why?
|
| Posture | 1 | 2014 | 957 | 0.020 |
Why?
|
| Models, Biological | 1 | 2006 | 9582 | 0.020 |
Why?
|
| Ultrasonography, Interventional | 1 | 2017 | 1486 | 0.020 |
Why?
|
| Lymphopenia | 1 | 2011 | 285 | 0.020 |
Why?
|
| Thrombin | 1 | 1991 | 598 | 0.020 |
Why?
|
| Isoantigens | 2 | 2001 | 567 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2014 | 2298 | 0.020 |
Why?
|
| Conscious Sedation | 1 | 2013 | 527 | 0.020 |
Why?
|
| Receptors, Mineralocorticoid | 1 | 2010 | 164 | 0.020 |
Why?
|
| Causality | 1 | 2015 | 1275 | 0.020 |
Why?
|
| Catheterization, Central Venous | 1 | 2013 | 514 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 2009 | 803 | 0.020 |
Why?
|
| Pathology, Molecular | 1 | 2011 | 326 | 0.020 |
Why?
|
| Cell Line | 1 | 2003 | 15993 | 0.020 |
Why?
|
| United States | 2 | 2019 | 69859 | 0.020 |
Why?
|
| Age Distribution | 1 | 2014 | 2899 | 0.020 |
Why?
|
| Protein Kinase C-delta | 1 | 2008 | 123 | 0.020 |
Why?
|
| Chemokine CCL21 | 1 | 2007 | 51 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 2009 | 667 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 2 | 2007 | 1524 | 0.020 |
Why?
|
| Prevalence | 2 | 2015 | 15211 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2009 | 2914 | 0.020 |
Why?
|
| Fear | 1 | 2016 | 1438 | 0.020 |
Why?
|
| Phenotype | 3 | 2017 | 16361 | 0.020 |
Why?
|
| Respiratory Burst | 1 | 2007 | 114 | 0.020 |
Why?
|
| Atherectomy | 1 | 2007 | 47 | 0.020 |
Why?
|
| Arteries | 1 | 2012 | 1119 | 0.020 |
Why?
|
| Genes, Lethal | 1 | 2008 | 242 | 0.020 |
Why?
|
| Receptor, erbB-2 | 2 | 2009 | 2418 | 0.020 |
Why?
|
| Creatine Kinase | 1 | 2009 | 694 | 0.020 |
Why?
|
| Violence | 1 | 2014 | 909 | 0.020 |
Why?
|
| Stress, Mechanical | 1 | 2012 | 1684 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2013 | 3128 | 0.020 |
Why?
|
| Lens, Crystalline | 1 | 2009 | 388 | 0.020 |
Why?
|
| Neoplasms, Experimental | 2 | 2003 | 1272 | 0.020 |
Why?
|
| Embryo Loss | 1 | 2007 | 59 | 0.020 |
Why?
|
| Molecular Probes | 1 | 2009 | 315 | 0.020 |
Why?
|
| HIV-1 | 1 | 2005 | 6939 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2009 | 3622 | 0.020 |
Why?
|
| Karyotyping | 1 | 2009 | 1243 | 0.020 |
Why?
|
| Esterification | 1 | 2006 | 36 | 0.020 |
Why?
|
| Coronary Disease | 1 | 2001 | 6078 | 0.020 |
Why?
|
| Family | 1 | 2017 | 3144 | 0.020 |
Why?
|
| Superoxides | 1 | 2007 | 387 | 0.020 |
Why?
|
| Atrial Fibrillation | 1 | 2005 | 5033 | 0.020 |
Why?
|
| Models, Cardiovascular | 2 | 2002 | 996 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2010 | 1588 | 0.020 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2009 | 648 | 0.020 |
Why?
|
| North America | 1 | 2010 | 1249 | 0.020 |
Why?
|
| Motor Activity | 1 | 2016 | 2714 | 0.020 |
Why?
|
| Transgenes | 1 | 2009 | 1008 | 0.020 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2014 | 1018 | 0.020 |
Why?
|
| Ovariectomy | 1 | 2008 | 661 | 0.020 |
Why?
|
| Interleukin-17 | 1 | 2012 | 902 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2008 | 513 | 0.020 |
Why?
|
| Hemodynamics | 2 | 2007 | 4197 | 0.020 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2009 | 690 | 0.020 |
Why?
|
| Chemokine CXCL12 | 1 | 2007 | 465 | 0.020 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2013 | 980 | 0.020 |
Why?
|
| Genomics | 1 | 2021 | 5714 | 0.020 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2006 | 124 | 0.020 |
Why?
|
| Radiographic Image Enhancement | 1 | 2010 | 885 | 0.020 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2008 | 488 | 0.020 |
Why?
|
| Endocarditis | 1 | 2009 | 349 | 0.020 |
Why?
|
| Child | 3 | 2022 | 77637 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2012 | 1403 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2013 | 2037 | 0.020 |
Why?
|
| DNA, Viral | 1 | 2011 | 2226 | 0.020 |
Why?
|
| Morphogenesis | 1 | 2008 | 751 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2009 | 1011 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2014 | 2241 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 16674 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 2727 | 0.020 |
Why?
|
| Alloys | 1 | 2005 | 122 | 0.020 |
Why?
|
| Polyurethanes | 1 | 2005 | 107 | 0.020 |
Why?
|
| Virus Assembly | 1 | 2005 | 144 | 0.020 |
Why?
|
| Keratin-10 | 1 | 2003 | 8 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2015 | 3510 | 0.010 |
Why?
|
| Gene Expression Profiling | 2 | 2015 | 9440 | 0.010 |
Why?
|
| Observer Variation | 1 | 2010 | 2592 | 0.010 |
Why?
|
| Filtration | 1 | 2005 | 233 | 0.010 |
Why?
|
| Canada | 1 | 2009 | 2064 | 0.010 |
Why?
|
| Gadolinium DTPA | 1 | 2007 | 836 | 0.010 |
Why?
|
| Hindlimb | 1 | 2006 | 503 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6539 | 0.010 |
Why?
|
| Protein Structure, Quaternary | 1 | 2005 | 436 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2014 | 2583 | 0.010 |
Why?
|
| Annexin A5 | 1 | 2003 | 103 | 0.010 |
Why?
|
| ras-GRF1 | 1 | 2003 | 26 | 0.010 |
Why?
|
| Transplantation, Homologous | 2 | 2002 | 4777 | 0.010 |
Why?
|
| bcl-Associated Death Protein | 1 | 2003 | 107 | 0.010 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2009 | 1335 | 0.010 |
Why?
|
| Gene Expression | 2 | 2008 | 7793 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-rel | 1 | 2002 | 71 | 0.010 |
Why?
|
| Guanosine Triphosphate | 1 | 2003 | 321 | 0.010 |
Why?
|
| Self Tolerance | 1 | 2003 | 125 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2003 | 829 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 2009 | 1904 | 0.010 |
Why?
|
| Cloning, Molecular | 2 | 2003 | 4320 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2011 | 2506 | 0.010 |
Why?
|
| Motor Skills | 1 | 2006 | 522 | 0.010 |
Why?
|
| Retrograde Degeneration | 1 | 2002 | 8 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2009 | 2649 | 0.010 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2002 | 107 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2003 | 821 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2014 | 4803 | 0.010 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2007 | 518 | 0.010 |
Why?
|
| Fibrin | 1 | 2005 | 505 | 0.010 |
Why?
|
| Axotomy | 1 | 2002 | 73 | 0.010 |
Why?
|
| Rats, Inbred WF | 1 | 2001 | 140 | 0.010 |
Why?
|
| Polycythemia Vera | 1 | 2003 | 164 | 0.010 |
Why?
|
| Phagocytosis | 1 | 2007 | 1539 | 0.010 |
Why?
|
| Keratins | 1 | 2003 | 515 | 0.010 |
Why?
|
| Anxiety | 1 | 2016 | 4288 | 0.010 |
Why?
|
| Vertebrates | 1 | 2003 | 228 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 2003 | 683 | 0.010 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2005 | 506 | 0.010 |
Why?
|
| E2F1 Transcription Factor | 1 | 2002 | 190 | 0.010 |
Why?
|
| Acute-Phase Reaction | 1 | 2001 | 92 | 0.010 |
Why?
|
| bcl-X Protein | 1 | 2003 | 411 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2013 | 3778 | 0.010 |
Why?
|
| E2F Transcription Factors | 1 | 2002 | 277 | 0.010 |
Why?
|
| Genotype | 1 | 2016 | 12944 | 0.010 |
Why?
|
| Ribonucleases | 1 | 2002 | 284 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2009 | 2266 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2003 | 743 | 0.010 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2009 | 1986 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 2002 | 438 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 2012 | 2217 | 0.010 |
Why?
|
| Fellowships and Scholarships | 1 | 2010 | 1077 | 0.010 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2004 | 549 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2002 | 8035 | 0.010 |
Why?
|
| Transplantation | 1 | 2002 | 217 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2006 | 2274 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2002 | 264 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2009 | 2504 | 0.010 |
Why?
|
| Cathepsins | 1 | 2001 | 238 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2009 | 2764 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 2003 | 1422 | 0.010 |
Why?
|
| Carotenoids | 1 | 2003 | 623 | 0.010 |
Why?
|
| Epidermis | 1 | 2003 | 529 | 0.010 |
Why?
|
| Embryonic Stem Cells | 1 | 2008 | 1295 | 0.010 |
Why?
|
| Fibrosis | 1 | 2007 | 2030 | 0.010 |
Why?
|
| Fetus | 1 | 2008 | 1880 | 0.010 |
Why?
|
| Aging | 2 | 2014 | 8655 | 0.010 |
Why?
|
| Spironolactone | 1 | 2003 | 382 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2009 | 2110 | 0.010 |
Why?
|
| Histocompatibility Testing | 1 | 2002 | 741 | 0.010 |
Why?
|
| Neurofilament Proteins | 1 | 2002 | 318 | 0.010 |
Why?
|
| Rats, Inbred Lew | 1 | 2001 | 1162 | 0.010 |
Why?
|
| Sodium, Dietary | 1 | 2003 | 418 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2012 | 3389 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2009 | 2938 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2003 | 1202 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 7908 | 0.010 |
Why?
|
| Keratinocytes | 1 | 2003 | 796 | 0.010 |
Why?
|
| Rabbits | 1 | 2006 | 4894 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 2012 | 3530 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2002 | 1826 | 0.010 |
Why?
|
| Equipment Design | 1 | 2007 | 3574 | 0.010 |
Why?
|
| Matrix Metalloproteinases | 1 | 2001 | 391 | 0.010 |
Why?
|
| Kidney Transplantation | 1 | 2014 | 4251 | 0.010 |
Why?
|
| Genes | 1 | 2003 | 1893 | 0.010 |
Why?
|
| Stem Cells | 1 | 2012 | 3566 | 0.010 |
Why?
|
| Germ-Line Mutation | 1 | 2007 | 1787 | 0.010 |
Why?
|
| Algorithms | 2 | 2014 | 13869 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2014 | 7729 | 0.010 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2002 | 675 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 2003 | 1227 | 0.010 |
Why?
|
| Collagen Type I | 1 | 2001 | 592 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 2002 | 1263 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 4326 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2014 | 6237 | 0.010 |
Why?
|
| Neocortex | 1 | 2002 | 399 | 0.010 |
Why?
|
| Benzamides | 1 | 2003 | 1383 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2002 | 1369 | 0.010 |
Why?
|
| Tomography, Optical Coherence | 1 | 2010 | 2657 | 0.010 |
Why?
|
| Curriculum | 1 | 2010 | 3603 | 0.010 |
Why?
|
| Immunologic Memory | 1 | 2003 | 1347 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2007 | 2916 | 0.010 |
Why?
|
| Cell Death | 1 | 2002 | 1705 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2003 | 3000 | 0.010 |
Why?
|
| Databases, Genetic | 1 | 2003 | 1782 | 0.010 |
Why?
|
| Swine | 1 | 2006 | 5909 | 0.010 |
Why?
|
| Phylogeny | 1 | 2003 | 2796 | 0.010 |
Why?
|
| Cholesterol | 1 | 2005 | 2922 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2009 | 7719 | 0.010 |
Why?
|
| Incidence | 1 | 2013 | 20948 | 0.010 |
Why?
|
| Image Enhancement | 1 | 2006 | 2915 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2003 | 4737 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2005 | 5445 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2003 | 1888 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2002 | 2749 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2003 | 3749 | 0.010 |
Why?
|
| Catheter Ablation | 1 | 2006 | 2758 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2002 | 3208 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2003 | 2961 | 0.010 |
Why?
|
| Operon | 1 | 1991 | 363 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2002 | 4422 | 0.010 |
Why?
|
| Seizures | 1 | 2003 | 2850 | 0.010 |
Why?
|
| Catalysis | 1 | 1991 | 762 | 0.010 |
Why?
|
| Genome, Human | 1 | 2003 | 4418 | 0.010 |
Why?
|
| Brain Ischemia | 1 | 2003 | 3264 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1991 | 2183 | 0.000 |
Why?
|
| Gene Expression Regulation | 1 | 2002 | 12066 | 0.000 |
Why?
|
| Genetic Vectors | 1 | 1991 | 3421 | 0.000 |
Why?
|
| Promoter Regions, Genetic | 1 | 1991 | 5867 | 0.000 |
Why?
|
| Bacterial Proteins | 1 | 1991 | 3850 | 0.000 |
Why?
|